Peptide Therapy
Therapeutic use of bioactive peptides to optimize hormones, enhance healing, modulate immunity, and support longevity.
Evidence Summary
Individual peptides have varying evidence levels. BPC-157 and TB-500 have strong preclinical data. GHRH/GHRP combinations well-studied. Regulatory landscape evolving.
Evidence Scale
Mechanism of Action
Various peptides act as secretagogues, growth factors, or signaling molecules. Common examples stimulate GH release, enhance tissue repair, or modulate inflammation.
Who Is This For?
Tissue healing, GH optimization, cognitive enhancement, immune modulation. Individual peptide indications vary.
Protocol & Dosing
Dose
Varies by peptide. BPC-157: 250-500mcg daily. CJC/Ipamorelin: 100-300mcg each.
Frequency
Daily to 5 days/week
Duration
Cycles of 4-12 weeks
Protocol Summary
Subcutaneous injections, oral, or nasal administration depending on peptide. Cycling often recommended.
Interactions & Precautions
Contraindications
- Pregnancy
- Active cancer (for growth-promoting peptides)
- Individual peptide-specific contraindications
Potential Risks
- •Unregulated sources
- •Limited human data for some
- •Regulatory issues
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Source quality critical. BPC-157 excellent for gut and musculoskeletal. CJC-1295/Ipamorelin for GH axis. Thymosin alpha-1 for immunity.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation